ANGIOtensin Agents and Reduction of AntiDEPRESSANT Drugs' Prescription (ANGIODEPRESSANTS): A Cohort Study Using Real-World Data.

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/46105
• EU PAS number:
  EUPAS43831
• Study ID:
  46105
• Official title and acronym:
  ANGIOtensin Agents and Reduction of AntiDEPRESSANT Drugs' Prescription (ANGIODEPRESSANTS): A Cohort Study Using Real-World Data.
• DARWIN EU® study:
  No
• Study countries:
  Spain
• Study description:
  A retrospective cohort study will be performed by analyzing data obtained from the Catalan Southern Metropolitan data warehouse system, which collects data from both hospitalized and primary care patients from the Bellvitge University Hospital's area of influence. The investigators will begin by gathering information only on patients treated with antihypertensive drugs, which then will be stratified in two groups: 1) Angiotensin Agents group, 2) Other Antihypertensive Agents (Non-Angiotensin Agents) group. Afterwards, a separated analysis will be performed to assess the effects of ARBs and ACEIs separately on the prescription of antidepressant drugs.
• Study status:
  Planned

Research institutions and networks

Institutions

Bellvitge University Hospital

Study timelines

Date when funding contract was signed

Actual: 18/02/2020

Study start date

Planned: 03/04/2022

Date of final study report

Planned: 30/10/2022

Sources of funding

Other

More details on funding

Investigators own resources

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

ClinicalTrials.gov: NCT04899206